Author

Yizhi Cao

University of Michigan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Arul M. ChinnaiyaniD· 2 shared Gabriel CruziD· 2 shared Radha Paturu· 2 shared Rahul MannaniD· 2 shared Somnath Mahapatra· 2 shared Stephanie J. MineriD· 2 shared Xuhong CaoiD· 2 shared Yuanyuan QiaoiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Arul M. ChinnaiyanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A druggable chromatin vulnerability in suppressive neutrophils restores antitumor immunity

Fan Yang, Yi Bao, Yuanyuan Qiao, Gabriel Cruz, Eleanor Young, Rahul Mannan, Yuping Zhang, Matt Goodrich, Yizhi Cao, Jie Luo, Radha Paturu, Somnath Mahapatra, Jean Ching-Yi Tien, Royce Xu, Mikoto Kobayashi, , Arul M. Chinnaiyan

This paper identifies a druggable chromatin vulnerability in suppressive neutrophils that can restore antitumor immunity through mSWI/SNF antagonists.

bioRxiv · Sep 28, 2026 · PreprintCancer Biology

A Stress-Adaptive Lipid Kinase Axis Defines Metabolic Vulnerabilities in Neuroendocrine Prostate Cancer

Yang Zheng, Caleb Cheng, Yizhi Cao, Gabriel Cruz, Yuping Zhang, Radha Paturu, Somnath Mahapatra, Jing Hu, Rahul Mannan, Hüseyin Karabürk, Rupam Bhattacharyya, Yitong Yin, Yi Zhao, Wenyan Liu, Xuhong Cao, , Yuanyuan Qiao

This study identifies a stress-lipid kinase axis in NEPC driven by PIKfyve, revealing a synthetic vulnerability between PIKfyve and FASN that can be exploited for therapeutic targeting.

Cancer Cell · Aug 3, 2026Peer-reviewedCancer Biology